Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Theradaptive is a biopharmaceutical company dedicated to transforming the field of regenerative medicine. They specialize in developing proprietary protein-based therapeutics designed for precise tissue repair and regeneration, particularly in orthopedics, spine, and dental applications. Their platform technology aims to create materials that can be delivered precisely to the site of injury, promoting healing and reducing complications associated with existing treatments. The company focuses on translating scientific breakthroughs into clinically meaningful solutions for patients with debilitating conditions.
Serves as the primary center for research and development, corporate operations, and strategic management.
State-of-the-art laboratory facilities designed for advanced biopharmaceutical research and development, supporting their protein engineering and regenerative medicine platform.
A dynamic and innovative environment focused on scientific excellence, collaboration, and a mission-driven approach to developing breakthrough therapies. Emphasizes teamwork and problem-solving in a fast-paced biotech setting.
Strategically located within Maryland's prominent biotech hub, providing access to a skilled talent pool, research institutions, and a supportive ecosystem for life sciences companies.
While Theradaptive's physical operations are primarily based in Maryland, USA, its research and development efforts aim to address global healthcare needs in orthopedics and regenerative medicine. The company's innovative therapies have the potential for worldwide application, and it likely engages in international collaborations, seeks global regulatory approvals, and plans for future international market access.
8435 Progress Drive, Suite W
Frederick
MD
USA
Address: 100 Medimmune Way, Suite 240, Gaithersburg, MD 20878
Leverages the rich life sciences ecosystem of Gaithersburg and Montgomery County for talent acquisition, collaboration, and access to specialized research infrastructure.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Theradaptive' leadership includes:
Theradaptive has been backed by several prominent investors over the years, including:
Theradaptive has strengthened its executive team in the past year, notably with the appointment of John Greenbaum as Chief Financial Officer to support its growth and financing strategies. No major executive departures have been publicly announced.
Discover the tools Theradaptive uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Theradaptive likely utilizes common professional email formats for its employees. A common pattern is the first initial followed by the last name, or first name.last name.
[first_initial][last]@theradaptive.com
Format
lalvarez@theradaptive.com
Example
85%
Success rate
Business Wire • October 11, 2023
Theradaptive, Inc., a privately held biopharmaceutical company pioneering a new class of regenerative medicines, today announced the closing of a $50 million Series A extension. The financing was led by an undisclosed investor with significant participation from existing investors including the Maryland Momentum Fund and the University System of Maryland (USM) Momentum Fund....more
Business Wire • August 15, 2023
Theradaptive, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Medical Device designation for its OsteoAdapt SP, an investigational spinal fusion therapeutic for transforaminal lumbar interbody fusion (TLIF)....more
PR Newswire • May 2, 2023
Theradaptive, Inc., a biopharmaceutical company developing a new class of regenerative medicines, today announced the enrollment of the first patient in its Phase I/II clinical trial evaluating OsteoAdapt SP for transforaminal lumbar interbody fusion (TLIF)....more
Theradaptive Website/News Section • November 15, 2023
Theradaptive announced the appointment of John Greenbaum as its new Chief Financial Officer. Mr. Greenbaum brings over 20 years of experience in financial leadership roles within the life sciences industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Theradaptive, are just a search away.